The PE ratio for Encompass Health stock stands at 21.23 as of Oct 2, 2023. This results from the current EPS of $3.14 and stock price of $66.65. An increase of 6% has been seen in the P/E ratio compared to the average of 20.0 of the last 4 quarters.
Over the last ten years, the average PE ratio of Encompass Health has been 18.99. The current 21.23 PE ratio is 12% above the historical average. Over the past ten years, EHC's PE ratio was at its highest in the Dec 2020 quarter at 28.81, with a price of $82.69 and an EPS of $2.87. The Dec 2013 quarter recorded the bottom point at 12.91, with a price of $33.32 and an EPS of $2.58.
Maximum annual increase: 51.79% in 2020
Maximum annual decrease: -45.4% in 2021
Year | PE ratio | Change |
---|---|---|
2022 | 21.99 | 39.8% |
2021 | 15.73 | -45.4% |
2020 | 28.81 | 51.79% |
2019 | 18.98 | -8.31% |
2018 | 20.7 | 20.63% |
2017 | 17.16 | 15.25% |
2016 | 14.89 | -13.58% |
2015 | 17.23 | 10.24% |
2014 | 15.63 | 21.07% |
2013 | 12.91 | 2.14% |
EHC's current P/E ratio is above the 3, 5 and 10-year historical averages.
EHC's PE ratio is higher than its peer stock SEM.
Stock name | PE ratio | Market cap |
---|---|---|
SEM Select Medical Holdings Corp | 15.38 | $3.13B |
EHC Encompass Health Corp | 21 | $6.61B |
NVOS Novo Integrated Sciences Inc | N/A | $46.98M |
As of Oct 2, 2023, EHC stock has a price to earnings ratio of 21.23.
The average PE ratio for EHC stock over the past 3 years is 20.43.
The average PE ratio for EHC stock over the past 5 years is 20.33.
In the last ten years, the Dec 2020 quarter recorded the highest quarterly PE ratio at 28.81.
EHC's price to earnings ratio is currently 12% above its 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Oct 2, 2023), Encompass Health's stock price is $66.65. The earnings per share for the trailing twelve months (TTM) ending Jun 2023 is $3.14. Therefore, Encompass Health's P/E ratio for today is 21.23. PE RATIO(21.23) = STOCK PRICE($66.65) / TTM EPS($3.14)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.